David C Yeomans

USPTO Granted Patents = 14 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 120(Granted Patents)

Company Filing History:

8 out of 5,303

Leland Stanford Junior University

Healthpartners Research Foundation

Tonix Pharmaceuticals Holding Corp.

patents

6. 1 out of 11

Healthpartners Research & Education

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12156897 - Magnesium-containing oxytocin formulations and methods of use (2024-12-03),

2. 11970554 - Labeled oxytocin and method of manufacture and use (2024-04-30),

3. 11389473 - Magnesium-containing oxytocin formulations and methods of use (2022-07-19),

4. 10513525 - Methods and compositions for studying, imaging, and treating pain (2019-12-24),

5. 9629894 - Magnesium-containing oxytocin formulations and methods of use (2017-04-25),

6. 9238053 - Methods for treatment of pain (2016-01-19),

7. 9174999 - Methods and compositions for studying, imaging, and treating pain (2015-11-03),

8. 8551949 - Methods for treatment of pain (2013-10-08),

9. 8501691 - Methods for treatment of headaches by administration of oxytocin (2013-08-06),

10. 8258096 - Therapy procedure for drug delivery for trigeminal pain (2012-09-04),

11. 8252745 - Methods for treatment of headaches by administration of oxytocin (2012-08-28),

12. 8202838 - Methods for treatment of headaches by administration of oxytocin (2012-06-19),

13. 8198240 - Methods for treatment of headaches by administration of oxytocin (2012-06-12),

14. 7459424 - Peptide inhibitors of protein kinase C γ for pain management (2008-12-02),

Title: The Innovative Contributions of David C. Yeomans

Introduction

David C. Yeomans is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of medical research, particularly in the treatment of autism spectrum disorders. With a total of 14 patents to his name, Yeomans has demonstrated a commitment to advancing scientific knowledge and improving patient outcomes.

Latest Patents

Among his latest patents are innovative formulations and methods that utilize magnesium-containing oxytocin. These methods aim to treat autism spectrum disorder and related symptoms by co-administering an oxytocin peptide with magnesium ions. This combination has shown a synergistic effect in reducing social and communication deficits in affected patients. Another notable patent involves N-oxytocin molecules, detailing their manufacture and use in determining the distribution and kinetics of these molecules after various application methods.

Career Highlights

David C. Yeomans has worked with esteemed institutions such as Leland Stanford Junior University and Trigemina, Inc. His work has been pivotal in exploring new therapeutic avenues for complex disorders. His research has not only contributed to academic knowledge but has also paved the way for potential clinical applications.

Collaborations

Throughout his career, Yeomans has collaborated with notable colleagues, including Martin S. Angst and Daniel Jacobs. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

David C. Yeomans exemplifies the spirit of innovation in the medical field. His patents and research efforts continue to influence the treatment of autism spectrum disorders, showcasing the importance of collaboration and creativity in scientific advancement.

This text is generated by artificial intelligence and may not be accurate.